What happened at the OHSU Startup Symposium?

For the third consecutive year, TTBD hosted OHSU’s Annual Startup Symposium on Thursday, Nov. 6, for more than 200 participants in the OHSU Auditorium. The theme and focus of this year’s event “Changing Investment Landscape for Life Science Companies & Early Stage Technologies” brought local business experts and leaders as well as industry representatives and investors from out of state to connect and meet one-to-one with OHSU faculty and startup companies. This symposium provided an exclusive opportunity for participants to learn from one another, identify next steps for financing, and establish new contacts and relationships in the industry. Some of the companies that attended from across the nation included: Accelerator Corporation, Allegory Venture Partners, Decheng Capital, GE Healthcare Ventures, Global Good & Research at Intellectual Ventures, Lilly Ventures, Takeda Pharmaceuticals, and Welch Allyn.

The symposium included two keynote speakers and panels on traditional venture capital investment, corporate venture investment, things to know before you start a company, and startup models and incubators at other universities. More than 50 pre-selected, one-to-one partnering meetings between industry/investor representatives and OHSU startup companies occurred concurrently throughout the afternoon. TTBD will be following up with companies, investors and startups for any immediate and long-term outcomes from the day-long event.

“The meetings with VCs was a very informative and interactive process that allowed us to learn from the experience and hone our skills at presenting in a concise but impactful manner. Having a range of potential investors was an added benefit, as it allowed us to find how our pitch resonated with different VCs.”– Linn Goldberg, Managing Partner at Odyssey Science Innovations, an OHSU Startup

OHSU innovators interested in starting their own company are encouraged to contact TTBD to discuss the invention and thoughts about developing and commercializing the intellectual property through a startup company.

See the full videos of the opening remarks and the event keynotes by visiting the Technology Transfer and Business Development website.

NIH supplemental funding opportunity: Adding gender factors to study considerations

The Office of Research on Women’s Health (ORWH) has announced the availability of administrative supplements to NIH-funded researchers to encourage the consideration of sex/gender factors in their ongoing research. If you currently have NIH funding under one of the following mechanisms, you may be eligible : P01, P20, P30, P50, P60, PM1, U10, U19, U54, U56, UM1, DP!, DP2, DP3, DP4, DP5/UP5, RM1, R01, R15, R37, and U01.

The proposed research must address at least one objective from Goals 1 through 3 of the NIH Strategic Plan for Women’s Health Research. The following approaches are considered responsive to the intent of the supplement:

  • Adding the Opposite Sex: The addition of animal or human subjects, tissues or cells of the sex opposite to those used in the parent grant to allow sex-based comparisons.
  • Increasing Sample Size: The addition of more animal or human subjects, tissues or cells to a sample which already includes both males and females in order to increase the power of a study to analyze for a sex/gender difference.
  • Conducting New Comparative Analyses: Sex/gender comparative analyses of existing samples or datasets.
  • Single Sex Study (with justification): Applicants proposing to use subjects of only one sex may be considered responsive if the administrative supplement request addresses how the data obtained will address and inform the influence of sex on health and disease.

Please see the announcement or contact funding@ohsu.edu for further details.

NIH is really, truly implementing the new biosketch format

While you were enjoying your holidays, Sally Rockey announced last week that the NIH really, truly is implementing the new 5-page biosketch format with the annotated bibliography section detailing the importance of your contributions to science. This format applies to projects beginning in 2016, but that means applications with due dates as early as January 2015–so it’s not too soon to start preparing. This change will require you to spend some time thinking about, rewriting, and reformatting your existing biosketch. Research Funding & Development Services will be holding workshops on this format starting in January. Stay tuned.

Update: Hot off the presses, NIH has pushed the implementation date to May 25th. Keep those cards and letters to the post on NIH Extramural News coming.

OHSU Center for Women’s Health accepting proposals

The OHSU Center for Women’s Health Circle of Giving is now accepting submissions for its 2015 Women’s Health Research Funding Opportunity, due Jan. 16, 2015. Circle of Giving funding is intended to support new or established investigators interested in developing innovative directions in women’s health research.

Applications will be accepted from faculty at the rank of lecturer, assistant, associate, or full professor. Applications may be in basic science, clinical investigation, population health, or behavioral research. The pilot project conducted using these seed funds is expected to lead to additional research funded by federal and non-federal sources. The proposed research must be intended to produce a tangible improvement in women’s health.

The Circle expects to award $125,000 to support one project for one year. There is a possibility that an additional $125,000 grant will be awarded to a researcher submitting an application specific to cancer research.

Please view the full RFP for additional information.

Post-award Focus: Federal Grants Management workshop, Dec. 10

There are still a few seats available in the upcoming Post–award Focus: Federal Grant Management workshop, where, through analysis of case studies, participants will consider the new OMB Uniform Guidance, the NIH Grants Policy Statement, “single-draw,” closeout rules, and OHSU forms and procedures.

Wednesday, Dec. 10, 2014
1 to 4 p.m.

Key course topics:

  • Post-award roles and responsibilities
  • Cost principles
  • Prior approval
  • Subrecipient monitoring
  • Audit

Ideally, participants will have completed Essentials of Grant Administration or have equivalent experience, as well as Oracle Grants Accounting.

Enroll using your network credentials through Compass. For questions, contact Margaret Gardner at rate@ohsu.edu.

OCTRI Design Studio: Get feedback on your project from senior faculty

Are you submitting a Career Development K award? Or your first R01? A similar major grant?

The Oregon Clinical and Translational Research Institute has an opportunity for basic and clinical scientists to present their research and get constructive feedback from OHSU scientists to improve their chances of success. The OCTRI Design Studio has helped many OHSU researchers improve their aims and identify important areas of improvement before submitting awards.

The Design Studio has openings at three scheduled meetings for this

  • Monday, Dec. 15, 1 to 3 p.m., Kohler Pavilion 13000A
  • Tuesday, Jan. 13, 12 to 2 p.m., Kohler Pavilion 13000A
  • Tuesday, Feb. 10, 12 to 2 p.m., Kohler Pavilion 13000A

OCTRI’s Design Studio has been a great opportunity for basic scientists as well as clinical scientists at all levels of training. Learn more about Design Studio, or contact Karen McCracken about presenting.

TTBD Lunch & Learn: Basics of Starting a Company, Dec. 16

The office of Technology Transfer & Business Development presents:
The basics of starting a company in an academic setting: Things you should know, follow or avoid

Are you interested in starting a company based on your invention?

The Director of Business Development, Jit Banerjee, and the Startup Development Associate, Daphne Emerson, will take you through the basic steps to starting a company based on your technology, including:

  • IP protection and assessment
  • Option or license negotiation
  • The initial startup team meeting
  • The final approval process

They will also review a list of startup launch steps – from company incorporation, to registering with the federal procurement system, to developing a website for your company.  Non-dilutive and dilutive funding, including the basics of SBIR/STTR grants, will also be briefly discussed.

Tuesday, Dec. 16, 2014
12 to 1 p.m.
OHSU Marquam Hill Campus
Mackenzie Hall 2201
Add it to your CALENDAR

This event is open to all OHSU employees, faculty and students. Admission is free, and no RSVP is necessary. The event will be catered. Lunches will be provided on a first-come, first-served basis. For any questions regarding this event, please e-mail Karen Boren at borenk@ohsu.edu.


OCTRI Research Forum: Power and Sample Size Simplified, Dec. 12

Join the Oregon Clinical and Translational Research Institute, OCTRI, in a monthly research forum that addresses all things clinical and translational research.

Don’t miss December’s topic: Power and Sample Size Simplified
Refresh your skills on calculating power and sample size for your research proposal. Work through examples in clinical and translational research and learn about tools and resources available to you through the Biostatistics and Design Program. Presented by David Yanez.

David Yanez

Presenter David Yanez

Friday, Dec. 12, 2014
12 to 1 p.m.
Mackenzie Hall 2201

OCTRI invites all faculty and staff to discuss issues and solutions to common obstacles in conducting clinical and translational research. Do you have a clinical or translational research question? Let us know, and we’ll do our best to help during these events! Please submit questions and topic requests to Colleen Berreta.

Click here for more information about the OCTRI Research Forum.

Save the date!
January OCTRI Research Forum:  Survey Design and Tools
Jan. 26, 2015
12 to 1 p.m.
Mackenzie Hall 2201

TTBD Industry Spotlight: Pitching to industry

Building partnerships between academic and corporate institutions is a mutually beneficial endeavor. These types of alliances have the potential to innovate and solve many medical, scientific, and health-related issues. Universities can bring a wealth of knowledge and research expertise, while partnering corporations provide the resources and connections necessary to help that research flourish. Although the paths to these partnerships can vary by institution, scientific alignment is the foundation of prosperous relationships.

The pharmaceutical, medical device, and biotech industries have a long history of collaboration with academia. When the goals of both parties are aligned, successful, long-term partnerships are much more likely to develop. The common paths taken for academic-corporate partnerships include:

  • Companies collaborating directly with individual faculty that may have unique expertise or resources
  • Faculty submitting either solicited or unsolicited proposals followed by internal evaluation and selection by the industry partner
  • An organization-to-organization broad, strategic relationship involving multiple projects
  • Consortia of companies and/or academic organizations

How can the success of these partnerships be ensured? First, both parties must be clear in outlining their goals up front in order to make the process as transparent as possible. Communication is critical when developing a new partnership. Second, decision makers must be accessible and openly supportive of development of the relationship. Third, project managers with strong collaboration skills and the necessary bandwidth in their schedules should be assigned to developing and maintaining the relationship.

There are few things to keep in mind when beginning this process:

  • When you find a potential prospect, it is important to remain flexible and responsive.
  • Due diligence at the beginning is normal and takes time.
  • Remember that most industry RFPs do not get funded, but often times feedback is provided, including options for re-submission.
  • Be patient. Relationship development can be a lengthy process as both institutions get to know each other.

TTBD periodically sends out Requests for Proposals solicited by different pharmaceutical and medical device companies. We encourage you to look at their websites for submission criteria in your areas of interest. Contact us if you plan on submitting a proposal and/or are in need of any guidance.

For more information, please contact our office at techmgmt@ohsu.edu.

Research Administration training and education: Effort Certification, DHHS Salary Cap

It seems like it was just yesterday that the previous Effort Certification cycle came to a close. The end of yet another effort cycle occurs on Dec. 31. Get a jump on your effort tracking and reporting process by considering these upcoming RATE classes:

Effort Certification – Tuesday, Dec. 2, 2014, 1  to 3 p.m. in CHH 3181 1B

Examine not only the federal requirements that shape institutional policy but also details of OHSU’s Effort Certification procedure, including reporting frequency and shared compliance responsibility. This class is for department Effort Coordinators and those supporting or overseeing the effort to certify Effort.

DHHS Salary Cap - Tuesday, Dec. 9, 2014, 1 to 3 p.m. in CHH 3181 1B

Gain tools for navigating the complex process of budgeting for and managing salaries affected by the DHHS Salary Cap. It’s recommended that participants have attended Effort Certification before this class.

Enrollment for either or both of these classes is now through Compass using your network credentials. For questions about this or any other RATE Classes, please contact Margaret Gardner.

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.